US4039663A
(en)
*
|
1975-03-19 |
1977-08-02 |
Societa' Farmaceutici Italia S.P.A. |
Daunomycins, process for their uses and intermediates
|
US4122092A
(en)
*
|
1977-08-25 |
1978-10-24 |
University Of Rochester |
Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone
|
US4294763A
(en)
*
|
1980-03-05 |
1981-10-13 |
University Of Rochester |
Intermediates for the production of picropodophyllin and related compounds and processes for the preparation and use thereof
|
DE3374317D1
(en)
*
|
1982-11-26 |
1987-12-10 |
Nippon Kayaku Kk |
Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
|
JPS6032799A
(ja)
*
|
1983-07-29 |
1985-02-19 |
Microbial Chem Res Found |
新規4′−デメチル−4−エピポドフィロトキシン誘導体
|
US4708964A
(en)
*
|
1984-02-09 |
1987-11-24 |
Chemex Pharmaceuticals |
Lipoxygenase inhibitors
|
US4713246A
(en)
*
|
1984-03-19 |
1987-12-15 |
Bristol-Myers Company |
Etoposide oral dosage form
|
US4609644A
(en)
*
|
1984-06-15 |
1986-09-02 |
St. Jude Children's Research Hospital |
Epipodophyllotoxinquinone glucoside derivatives, method of production and use
|
EP0184921A3
(en)
*
|
1984-12-08 |
1986-10-29 |
Beecham Group Plc |
Erythromycin derivatives
|
JPS61227590A
(ja)
*
|
1985-04-02 |
1986-10-09 |
Microbial Chem Res Found |
新規4′−デメチル−4−エピポドフイロトキシン誘導体
|
US4795819A
(en)
*
|
1985-04-12 |
1989-01-03 |
Bristol-Myers Company |
Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
|
US4866189A
(en)
*
|
1985-04-12 |
1989-09-12 |
Bristol-Myers Company |
Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
|
US4728740A
(en)
*
|
1985-04-12 |
1988-03-01 |
Bristol-Myers Company |
Intermediates for the production of epipodophylotoxin and related compounds and processes for the preparation and use thereof
|
US4644072A
(en)
*
|
1985-04-12 |
1987-02-17 |
Bristol-Myers Company |
Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
|
US5011948A
(en)
*
|
1985-04-12 |
1991-04-30 |
Bristol-Myers Company |
Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
|
US4916217A
(en)
*
|
1987-01-08 |
1990-04-10 |
Bristol-Myers Company |
Phosphorus containing derivatives of epipodophyllotoxin
|
US4853467A
(en)
*
|
1987-05-19 |
1989-08-01 |
Bristol-Myers Company |
Nitrogen containing derivatives of epipodophyllotoxin glucosides
|
US4874851A
(en)
*
|
1987-07-01 |
1989-10-17 |
Bristol-Meyers Company |
3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives
|
US4904768A
(en)
*
|
1987-08-04 |
1990-02-27 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside 4'-phosphate derivatives
|
US4868291A
(en)
*
|
1987-08-20 |
1989-09-19 |
Bristol-Myers Company |
4'-deshydroxyepipodophyllotoxin glucosides: synthesis and use
|
US4888419A
(en)
*
|
1987-08-31 |
1989-12-19 |
Bristol-Myers Company |
3'-demethoxyepipodophyllotoxin glucoside derivatives
|
ZA886810B
(en)
*
|
1987-12-18 |
1989-08-30 |
Bristol Myers Co |
Epipodophyllotoxin glucoside 4'-acyl derivatives
|
US4935504A
(en)
*
|
1987-12-18 |
1990-06-19 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside 4'-acyl derivatives
|
US4958010A
(en)
*
|
1988-02-16 |
1990-09-18 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside lactam derivatives
|
US4912204A
(en)
*
|
1988-09-06 |
1990-03-27 |
Bristol-Myers Company |
Fluoro-substituted epipodophyllotoxin glucosides
|
US5061791A
(en)
*
|
1988-12-21 |
1991-10-29 |
Warner-Lambert Company |
4-bromo-4'-demethylepipodophyllotoxin derivatives
|
WO1990009788A1
(en)
*
|
1989-02-23 |
1990-09-07 |
The University Of North Carolina At Chapel Hill |
Etoposide analogues
|
US4965348A
(en)
*
|
1989-05-19 |
1990-10-23 |
Bristol-Myers Company |
Dimeric epipodophyllotoxin glucoside derivatives
|
US5036055A
(en)
*
|
1989-06-07 |
1991-07-30 |
Bristol-Myers Company |
Acylated derivatives of etoposide
|
US5066645A
(en)
*
|
1989-09-01 |
1991-11-19 |
Bristol-Myers Company |
Epipodophyllotoxin altroside derivatives
|
US6610299B1
(en)
|
1989-10-19 |
2003-08-26 |
Aventis Pharma Deutschland Gmbh |
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
|
US6475486B1
(en)
|
1990-10-18 |
2002-11-05 |
Aventis Pharma Deutschland Gmbh |
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
|
US7241595B2
(en)
*
|
1989-10-20 |
2007-07-10 |
Sanofi-Aventis Pharma Deutschland Gmbh |
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
|
FR2655047A1
(fr)
*
|
1989-11-24 |
1991-05-31 |
Pf Medicament |
Derives d'etoposide, leur preparation et leur application comme intermediaires de synthese.
|
FR2658824B1
(fr)
*
|
1990-02-27 |
1992-07-03 |
Pf Medicament |
Tris acetyl-2",3",4' ethylidene-4",6" beta-d-glucopyranosides, leur preparation et leur utilisation pour la preparation d'ethylidene beta-d-glucopyranoside de demethyl-4' epipodophyllotoxine.
|
US5081234A
(en)
*
|
1990-04-30 |
1992-01-14 |
Bristol-Myers Squibb Co. |
4'-demethylepipodophyllotoxin glycosides
|
CN1025918C
(zh)
*
|
1990-06-07 |
1994-09-14 |
国家医药管理局上海医药工业研究院 |
抗肿瘤药表鬼臼毒吡喃糖甙的合成新工艺
|
US4997931A
(en)
*
|
1990-06-11 |
1991-03-05 |
Bristol-Myers Squibb Company |
Epipodophyllotoxin glycosides
|
JPH04221393A
(ja)
*
|
1990-12-20 |
1992-08-11 |
Kikkoman Corp |
N−アセチル−β−D−グルコサミン誘導体、これを有効成分とするN−アセチル−β−D−グルコサミニダーゼ活性測定用試薬及びこれを用いたN−アセチル−β−D−グルコサミニダーゼ活性の測定方法
|
US5459248A
(en)
*
|
1993-11-04 |
1995-10-17 |
Bristol-Myers Squibb Company |
Process of preparing etoposide phosphate and etoposide
|
GB9422946D0
(en)
*
|
1994-11-14 |
1995-01-04 |
Univ Salamanca |
Antineoplastic cyclolignan derivatives
|
WO1999032499A1
(en)
*
|
1997-12-23 |
1999-07-01 |
Korea Research Institute Of Chemical Technology |
4'-O-DEMETHYL-EPIPODOPHYLLOTOXIN-β-D-GLUCOSIDE ACETAL DERIVATIVES
|
CA2343803A1
(en)
|
1998-09-10 |
2000-03-23 |
Ragina Naidu |
Synthetic method for the preparation of the antineoplastic agent etoposide
|
AU775373B2
(en)
|
1999-10-01 |
2004-07-29 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
SE0002045D0
(sv)
*
|
2000-05-31 |
2000-05-31 |
Sahltech Ab |
New use
|
US7342114B2
(en)
*
|
2003-07-01 |
2008-03-11 |
California Pacific Medical Center |
Podophyllotoxin derivatives
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
SG172363A1
(en)
*
|
2008-12-23 |
2011-07-28 |
Pharmasset Inc |
Synthesis of purine nucleosides
|
CL2009002207A1
(es)
|
2008-12-23 |
2011-02-18 |
Gilead Pharmasset Llc |
Compuestos derivados de 3-hidroxi-5-(9h-purin-9-il)tetrahidrofuran-2-il, inhibidor de la replicacion de arn viral dependiente de arn; composicion farmaceutica; uso para el tratamiento de hepatitis c.
|
WO2010075517A2
(en)
*
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Nucleoside analogs
|
AP3515A
(en)
|
2010-03-31 |
2016-01-11 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
US10087194B2
(en)
|
2015-10-27 |
2018-10-02 |
California Pacific Medical Center |
Podophyllotoxin derivatives and their use
|
WO2017074325A1
(en)
|
2015-10-27 |
2017-05-04 |
California Pacific Medical Center |
Podophyllotoxin derivatives and their use
|
CN109232688B
(zh)
*
|
2018-10-17 |
2021-03-30 |
华南农业大学 |
一种具有高除草活性的天然木脂素类化合物及其应用
|
WO2023220641A2
(en)
|
2022-05-11 |
2023-11-16 |
Juno Therapeutics, Inc. |
Methods and uses related to t cell therapy and production of same
|